The global market for Human Factor VIII Concentrate was valued at US$ 199 million in the year 2024 and is projected to reach a revised size of US$ 261 million by 2031, growing at a CAGR of 4.0% during the forecast period.

Human Factor VIII Concentrate Market

Complementary therapy for prevention and treatment of hemophilia A acquired coagulation factor Ⅷ deficiency and von Willebrand"s disease

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Human Factor VIII Concentrate, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Human Factor VIII Concentrate.

The Human Factor VIII Concentrate market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Human Factor VIII Concentrate market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Human Factor VIII Concentrate manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Human Factor VIII Concentrate Market Report

Report Metric	Details
Report Name	Human Factor VIII Concentrate Market
Accounted market size in year	US$ 199 million
Forecasted market size in 2031	US$ 261 million
CAGR	4.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Blood Extraction Recombine
Segment by Application	Congenital Coagulation Factor VIII Deficiency Acquired Factor VIII Deficiency Von Willebrand's Disease
Consumption by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Asia-Pacific (China, Japan, South Korea, Taiwan) Southeast Asia (India) Latin America (Mexico, Brazil)
By Company	Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products, Shanghai Xinxing Medicine, SinoCell Tech, CSL, Grifols, Biogen, Octapharma, NovoNordisk
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Human Factor VIII Concentrate manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Human Factor VIII Concentrate in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.

FAQ for this report

How fast is Human Factor VIII Concentrate Market growing?

Ans: The Human Factor VIII Concentrate Market witnessing a CAGR of 4.0% during the forecast period 2025-2031.

What is the Human Factor VIII Concentrate Market size in 2031?

Ans: The Human Factor VIII Concentrate Market size in 2031 will be US$ 261 million.

Who are the main players in the Human Factor VIII Concentrate Market report?

Ans: The main players in the Human Factor VIII Concentrate Market are Pfizer, Novo Nordisk A/S, Shire (Baxter), Bayer, GC Pharma, Shanghai Raas Corp, Hualan Biological, Shandong Taibang Biological Products, Shanghai Xinxing Medicine, SinoCell Tech, CSL, Grifols, Biogen, Octapharma, NovoNordisk

What are the Application segmentation covered in the Human Factor VIII Concentrate Market report?

Ans: The Applications covered in the Human Factor VIII Concentrate Market report are Congenital Coagulation Factor VIII Deficiency, Acquired Factor VIII Deficiency, Von Willebrand's Disease

What are the Type segmentation covered in the Human Factor VIII Concentrate Market report?

Ans: The Types covered in the Human Factor VIII Concentrate Market report are Blood Extraction, Recombine

1 Human Factor VIII Concentrate Market Overview

1.1 Product Definition

1.2 Human Factor VIII Concentrate by Type

1.2.1 Global Human Factor VIII Concentrate Market Value Comparison by Type (2024 VS 2031)

1.2.2 Blood Extraction

1.2.3 Recombine

1.3 Human Factor VIII Concentrate by Application

1.3.1 Global Human Factor VIII Concentrate Market Value by Application (2024 VS 2031)

1.3.2 Congenital Coagulation Factor VIII Deficiency

1.3.3 Acquired Factor VIII Deficiency

1.3.4 Von Willebrand's Disease

1.4 Global Human Factor VIII Concentrate Market Size Estimates and Forecasts

1.4.1 Global Human Factor VIII Concentrate Revenue 2020-2031

1.4.2 Global Human Factor VIII Concentrate Sales 2020-2031

1.4.3 Global Human Factor VIII Concentrate Market Average Price (2020-2031)

1.5 Assumptions and Limitations

2 Human Factor VIII Concentrate Market Competition by Manufacturers

2.1 Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2020-2025)

2.2 Global Human Factor VIII Concentrate Revenue Market Share by Manufacturers (2020-2025)

2.3 Global Human Factor VIII Concentrate Average Price by Manufacturers (2020-2025)

2.4 Global Key Players of Human Factor VIII Concentrate, Industry Ranking, 2022 VS 2023 VS 2024

2.5 Global Key Manufacturers of Human Factor VIII Concentrate, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Human Factor VIII Concentrate, Product Type & Application

2.7 Global Key Manufacturers of Human Factor VIII Concentrate, Date of Enter into This Industry

2.8 Global Human Factor VIII Concentrate Market Competitive Situation and Trends

2.8.1 Global Human Factor VIII Concentrate Market Concentration Rate

2.8.2 The Global 5 and 10 Largest Human Factor VIII Concentrate Players Market Share by Revenue

2.8.3 Global Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

2.9 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Global Human Factor VIII Concentrate Market Scenario by Region

3.1 Global Human Factor VIII Concentrate Market Size by Region: 2020 Versus 2024 Versus 2031

3.2 Global Human Factor VIII Concentrate Sales by Region: 2020-2031

3.2.1 Global Human Factor VIII Concentrate Sales by Region: 2020-2025

3.2.2 Global Human Factor VIII Concentrate Sales by Region: 2026-2031

3.3 Global Human Factor VIII Concentrate Revenue by Region: 2020-2031

3.3.1 Global Human Factor VIII Concentrate Revenue by Region: 2020-2025

3.3.2 Global Human Factor VIII Concentrate Revenue by Region: 2026-2031

3.4 North America Human Factor VIII Concentrate Market Facts & Figures by Country

3.4.1 North America Human Factor VIII Concentrate Market Size by Country: 2020 VS 2024 VS 2031

3.4.2 North America Human Factor VIII Concentrate Sales by Country (2020-2031)

3.4.3 North America Human Factor VIII Concentrate Revenue by Country (2020-2031)

3.4.4 United States

3.4.5 Canada

3.5 Europe Human Factor VIII Concentrate Market Facts & Figures by Country

3.5.1 Europe Human Factor VIII Concentrate Market Size by Country: 2020 VS 2024 VS 2031

3.5.2 Europe Human Factor VIII Concentrate Sales by Country (2020-2031)

3.5.3 Europe Human Factor VIII Concentrate Revenue by Country (2020-2031)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Human Factor VIII Concentrate Market Facts & Figures by Region

3.6.1 Asia Pacific Human Factor VIII Concentrate Market Size by Region: 2020 VS 2024 VS 2031

3.6.2 Asia Pacific Human Factor VIII Concentrate Sales by Region (2020-2031)

3.6.3 Asia Pacific Human Factor VIII Concentrate Revenue by Region (2020-2031)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Southeast Asia

3.7 Latin America Human Factor VIII Concentrate Market Facts & Figures by Country

3.7.1 Latin America Human Factor VIII Concentrate Market Size by Country: 2020 VS 2024 VS 2031

3.7.2 Latin America Human Factor VIII Concentrate Sales by Country (2020-2031)

3.7.3 Latin America Human Factor VIII Concentrate Revenue by Country (2020-2031)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Human Factor VIII Concentrate Market Facts & Figures by Country

3.8.1 Middle East and Africa Human Factor VIII Concentrate Market Size by Country: 2020 VS 2024 VS 2031

3.8.2 Middle East and Africa Human Factor VIII Concentrate Sales by Country (2020-2031)

3.8.3 Middle East and Africa Human Factor VIII Concentrate Revenue by Country (2020-2031)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4 Segment by Type

4.1 Global Human Factor VIII Concentrate Sales by Type (2020-2031)

4.1.1 Global Human Factor VIII Concentrate Sales by Type (2020-2025)

4.1.2 Global Human Factor VIII Concentrate Sales by Type (2026-2031)

4.1.3 Global Human Factor VIII Concentrate Sales Market Share by Type (2020-2031)

4.2 Global Human Factor VIII Concentrate Revenue by Type (2020-2031)

4.2.1 Global Human Factor VIII Concentrate Revenue by Type (2020-2025)

4.2.2 Global Human Factor VIII Concentrate Revenue by Type (2026-2031)

4.2.3 Global Human Factor VIII Concentrate Revenue Market Share by Type (2020-2031)

4.3 Global Human Factor VIII Concentrate Price by Type (2020-2031)

5 Segment by Application

5.1 Global Human Factor VIII Concentrate Sales by Application (2020-2031)

5.1.1 Global Human Factor VIII Concentrate Sales by Application (2020-2025)

5.1.2 Global Human Factor VIII Concentrate Sales by Application (2026-2031)

5.1.3 Global Human Factor VIII Concentrate Sales Market Share by Application (2020-2031)

5.2 Global Human Factor VIII Concentrate Revenue by Application (2020-2031)

5.2.1 Global Human Factor VIII Concentrate Revenue by Application (2020-2025)

5.2.2 Global Human Factor VIII Concentrate Revenue by Application (2026-2031)

5.2.3 Global Human Factor VIII Concentrate Revenue Market Share by Application (2020-2031)

5.3 Global Human Factor VIII Concentrate Price by Application (2020-2031)

6 Key Companies Profiled

6.1 Pfizer

6.1.1 Pfizer Company Information

6.1.2 Pfizer Description and Business Overview

6.1.3 Pfizer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.1.4 Pfizer Human Factor VIII Concentrate Product Portfolio

6.1.5 Pfizer Recent Developments/Updates

6.2 Novo Nordisk A/S

6.2.1 Novo Nordisk A/S Company Information

6.2.2 Novo Nordisk A/S Description and Business Overview

6.2.3 Novo Nordisk A/S Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.2.4 Novo Nordisk A/S Human Factor VIII Concentrate Product Portfolio

6.2.5 Novo Nordisk A/S Recent Developments/Updates

6.3 Shire (Baxter)

6.3.1 Shire (Baxter) Company Information

6.3.2 Shire (Baxter) Description and Business Overview

6.3.3 Shire (Baxter) Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.3.4 Shire (Baxter) Human Factor VIII Concentrate Product Portfolio

6.3.5 Shire (Baxter) Recent Developments/Updates

6.4 Bayer

6.4.1 Bayer Company Information

6.4.2 Bayer Description and Business Overview

6.4.3 Bayer Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.4.4 Bayer Human Factor VIII Concentrate Product Portfolio

6.4.5 Bayer Recent Developments/Updates

6.5 GC Pharma

6.5.1 GC Pharma Company Information

6.5.2 GC Pharma Description and Business Overview

6.5.3 GC Pharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.5.4 GC Pharma Human Factor VIII Concentrate Product Portfolio

6.5.5 GC Pharma Recent Developments/Updates

6.6 Shanghai Raas Corp

6.6.1 Shanghai Raas Corp Company Information

6.6.2 Shanghai Raas Corp Description and Business Overview

6.6.3 Shanghai Raas Corp Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.6.4 Shanghai Raas Corp Human Factor VIII Concentrate Product Portfolio

6.6.5 Shanghai Raas Corp Recent Developments/Updates

6.7 Hualan Biological

6.7.1 Hualan Biological Company Information

6.7.2 Hualan Biological Description and Business Overview

6.7.3 Hualan Biological Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.7.4 Hualan Biological Human Factor VIII Concentrate Product Portfolio

6.7.5 Hualan Biological Recent Developments/Updates

6.8 Shandong Taibang Biological Products

6.8.1 Shandong Taibang Biological Products Company Information

6.8.2 Shandong Taibang Biological Products Description and Business Overview

6.8.3 Shandong Taibang Biological Products Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.8.4 Shandong Taibang Biological Products Human Factor VIII Concentrate Product Portfolio

6.8.5 Shandong Taibang Biological Products Recent Developments/Updates

6.9 Shanghai Xinxing Medicine

6.9.1 Shanghai Xinxing Medicine Company Information

6.9.2 Shanghai Xinxing Medicine Description and Business Overview

6.9.3 Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.9.4 Shanghai Xinxing Medicine Human Factor VIII Concentrate Product Portfolio

6.9.5 Shanghai Xinxing Medicine Recent Developments/Updates

6.10 SinoCell Tech

6.10.1 SinoCell Tech Company Information

6.10.2 SinoCell Tech Description and Business Overview

6.10.3 SinoCell Tech Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.10.4 SinoCell Tech Human Factor VIII Concentrate Product Portfolio

6.10.5 SinoCell Tech Recent Developments/Updates

6.11 CSL

6.11.1 CSL Company Information

6.11.2 CSL Description and Business Overview

6.11.3 CSL Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.11.4 CSL Human Factor VIII Concentrate Product Portfolio

6.11.5 CSL Recent Developments/Updates

6.12 Grifols

6.12.1 Grifols Company Information

6.12.2 Grifols Description and Business Overview

6.12.3 Grifols Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.12.4 Grifols Human Factor VIII Concentrate Product Portfolio

6.12.5 Grifols Recent Developments/Updates

6.13 Biogen

6.13.1 Biogen Company Information

6.13.2 Biogen Description and Business Overview

6.13.3 Biogen Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.13.4 Biogen Human Factor VIII Concentrate Product Portfolio

6.13.5 Biogen Recent Developments/Updates

6.14 Octapharma

6.14.1 Octapharma Company Information

6.14.2 Octapharma Description and Business Overview

6.14.3 Octapharma Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.14.4 Octapharma Human Factor VIII Concentrate Product Portfolio

6.14.5 Octapharma Recent Developments/Updates

6.15 NovoNordisk

6.15.1 NovoNordisk Company Information

6.15.2 NovoNordisk Description and Business Overview

6.15.3 NovoNordisk Human Factor VIII Concentrate Sales, Revenue and Gross Margin (2020-2025)

6.15.4 NovoNordisk Human Factor VIII Concentrate Product Portfolio

6.15.5 NovoNordisk Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

7.1 Human Factor VIII Concentrate Industry Chain Analysis

7.2 Human Factor VIII Concentrate Raw Material Supply Analysis

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Human Factor VIII Concentrate Production Mode & Process Analysis

7.4 Human Factor VIII Concentrate Sales and Marketing

7.4.1 Human Factor VIII Concentrate Sales Channels

7.4.2 Human Factor VIII Concentrate Distributors

7.5 Human Factor VIII Concentrate Customer Analysis

8 Human Factor VIII Concentrate Market Dynamics

8.1 Human Factor VIII Concentrate Industry Trends

8.2 Human Factor VIII Concentrate Market Drivers

8.3 Human Factor VIII Concentrate Market Challenges

8.4 Human Factor VIII Concentrate Market Restraints

9 Research Findings and Conclusion

10 Methodology and Data Source

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

FEATURED COMPANIES

Shandong Taibang Biological Products

Shanghai Xinxing Medicine

List of Tables

Table 1. Global Human Factor VIII Concentrate Market Value Comparison by Type (2024 VS 2031) & (US$ Million)

Table 2. Global Human Factor VIII Concentrate Market Value by Application (2024 VS 2031) & (US$ Million)

Table 3. Global Human Factor VIII Concentrate Market Competitive Situation by Manufacturers in 2024

Table 4. Global Human Factor VIII Concentrate Sales (K Units) of Key Manufacturers (2020-2025)

Table 5. Global Human Factor VIII Concentrate Sales Market Share by Manufacturers (2020-2025)

Table 6. Global Human Factor VIII Concentrate Revenue (US$ Million) by Manufacturers (2020-2025)

Table 7. Global Human Factor VIII Concentrate Revenue Share by Manufacturers (2020-2025)

Table 8. Global Market Human Factor VIII Concentrate Average Price (US$/Unit) of Key Manufacturers (2020-2025)

Table 9. Global Key Players of Human Factor VIII Concentrate, Industry Ranking, 2022 VS 2023 VS 2024

Table 10. Global Key Manufacturers of Human Factor VIII Concentrate, Manufacturing Sites & Headquarters

Table 11. Global Key Manufacturers of Human Factor VIII Concentrate, Product Type & Application

Table 12. Global Key Manufacturers of Human Factor VIII Concentrate, Date of Enter into This Industry

Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

Table 14. Global Human Factor VIII Concentrate by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Human Factor VIII Concentrate as of 2024)

Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

Table 16. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 17. Global Human Factor VIII Concentrate Sales by Region (2020-2025) & (K Units)

Table 18. Global Human Factor VIII Concentrate Sales Market Share by Region (2020-2025)

Table 19. Global Human Factor VIII Concentrate Sales by Region (2026-2031) & (K Units)

Table 20. Global Human Factor VIII Concentrate Sales Market Share by Region (2026-2031)

Table 21. Global Human Factor VIII Concentrate Revenue by Region (2020-2025) & (US$ Million)

Table 22. Global Human Factor VIII Concentrate Revenue Market Share by Region (2020-2025)

Table 23. Global Human Factor VIII Concentrate Revenue by Region (2026-2031) & (US$ Million)

Table 24. Global Human Factor VIII Concentrate Revenue Market Share by Region (2026-2031)

Table 25. North America Human Factor VIII Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 26. North America Human Factor VIII Concentrate Sales by Country (2020-2025) & (K Units)

Table 27. North America Human Factor VIII Concentrate Sales by Country (2026-2031) & (K Units)

Table 28. North America Human Factor VIII Concentrate Revenue by Country (2020-2025) & (US$ Million)

Table 29. North America Human Factor VIII Concentrate Revenue by Country (2026-2031) & (US$ Million)

Table 30. Europe Human Factor VIII Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 31. Europe Human Factor VIII Concentrate Sales by Country (2020-2025) & (K Units)

Table 32. Europe Human Factor VIII Concentrate Sales by Country (2026-2031) & (K Units)

Table 33. Europe Human Factor VIII Concentrate Revenue by Country (2020-2025) & (US$ Million)

Table 34. Europe Human Factor VIII Concentrate Revenue by Country (2026-2031) & (US$ Million)

Table 35. Asia Pacific Human Factor VIII Concentrate Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 36. Asia Pacific Human Factor VIII Concentrate Sales by Region (2020-2025) & (K Units)

Table 37. Asia Pacific Human Factor VIII Concentrate Sales by Region (2026-2031) & (K Units)

Table 38. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2020-2025) & (US$ Million)

Table 39. Asia Pacific Human Factor VIII Concentrate Revenue by Region (2026-2031) & (US$ Million)

Table 40. Latin America Human Factor VIII Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Latin America Human Factor VIII Concentrate Sales by Country (2020-2025) & (K Units)

Table 42. Latin America Human Factor VIII Concentrate Sales by Country (2026-2031) & (K Units)

Table 43. Latin America Human Factor VIII Concentrate Revenue by Country (2020-2025) & (US$ Million)

Table 44. Latin America Human Factor VIII Concentrate Revenue by Country (2026-2031) & (US$ Million)

Table 45. Middle East and Africa Human Factor VIII Concentrate Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Middle East and Africa Human Factor VIII Concentrate Sales by Country (2020-2025) & (K Units)

Table 47. Middle East and Africa Human Factor VIII Concentrate Sales by Country (2026-2031) & (K Units)

Table 48. Middle East and Africa Human Factor VIII Concentrate Revenue by Country (2020-2025) & (US$ Million)

Table 49. Middle East and Africa Human Factor VIII Concentrate Revenue by Country (2026-2031) & (US$ Million)

Table 50. Global Human Factor VIII Concentrate Sales (K Units) by Type (2020-2025)

Table 51. Global Human Factor VIII Concentrate Sales (K Units) by Type (2026-2031)

Table 52. Global Human Factor VIII Concentrate Sales Market Share by Type (2020-2025)

Table 53. Global Human Factor VIII Concentrate Sales Market Share by Type (2026-2031)

Table 54. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2020-2025)

Table 55. Global Human Factor VIII Concentrate Revenue (US$ Million) by Type (2026-2031)

Table 56. Global Human Factor VIII Concentrate Revenue Market Share by Type (2020-2025)

Table 57. Global Human Factor VIII Concentrate Revenue Market Share by Type (2026-2031)

Table 58. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2020-2025)

Table 59. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2026-2031)

Table 60. Global Human Factor VIII Concentrate Sales (K Units) by Application (2020-2025)

Table 61. Global Human Factor VIII Concentrate Sales (K Units) by Application (2026-2031)

Table 62. Global Human Factor VIII Concentrate Sales Market Share by Application (2020-2025)

Table 63. Global Human Factor VIII Concentrate Sales Market Share by Application (2026-2031)

Table 64. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2020-2025)

Table 65. Global Human Factor VIII Concentrate Revenue (US$ Million) by Application (2026-2031)

Table 66. Global Human Factor VIII Concentrate Revenue Market Share by Application (2020-2025)

Table 67. Global Human Factor VIII Concentrate Revenue Market Share by Application (2026-2031)

Table 68. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2020-2025)

Table 69. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2026-2031)

Table 70. Pfizer Company Information

Table 71. Pfizer Description and Business Overview

Table 72. Pfizer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 73. Pfizer Human Factor VIII Concentrate Product

Table 74. Pfizer Recent Developments/Updates

Table 75. Novo Nordisk A/S Company Information

Table 76. Novo Nordisk A/S Description and Business Overview

Table 77. Novo Nordisk A/S Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 78. Novo Nordisk A/S Human Factor VIII Concentrate Product

Table 79. Novo Nordisk A/S Recent Developments/Updates

Table 80. Shire (Baxter) Company Information

Table 81. Shire (Baxter) Description and Business Overview

Table 82. Shire (Baxter) Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 83. Shire (Baxter) Human Factor VIII Concentrate Product

Table 84. Shire (Baxter) Recent Developments/Updates

Table 85. Bayer Company Information

Table 86. Bayer Description and Business Overview

Table 87. Bayer Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 88. Bayer Human Factor VIII Concentrate Product

Table 89. Bayer Recent Developments/Updates

Table 90. GC Pharma Company Information

Table 91. GC Pharma Description and Business Overview

Table 92. GC Pharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 93. GC Pharma Human Factor VIII Concentrate Product

Table 94. GC Pharma Recent Developments/Updates

Table 95. Shanghai Raas Corp Company Information

Table 96. Shanghai Raas Corp Description and Business Overview

Table 97. Shanghai Raas Corp Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 98. Shanghai Raas Corp Human Factor VIII Concentrate Product

Table 99. Shanghai Raas Corp Recent Developments/Updates

Table 100. Hualan Biological Company Information

Table 101. Hualan Biological Description and Business Overview

Table 102. Hualan Biological Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 103. Hualan Biological Human Factor VIII Concentrate Product

Table 104. Hualan Biological Recent Developments/Updates

Table 105. Shandong Taibang Biological Products Company Information

Table 106. Shandong Taibang Biological Products Description and Business Overview

Table 107. Shandong Taibang Biological Products Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 108. Shandong Taibang Biological Products Human Factor VIII Concentrate Product

Table 109. Shandong Taibang Biological Products Recent Developments/Updates

Table 110. Shanghai Xinxing Medicine Company Information

Table 111. Shanghai Xinxing Medicine Description and Business Overview

Table 112. Shanghai Xinxing Medicine Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 113. Shanghai Xinxing Medicine Human Factor VIII Concentrate Product

Table 114. Shanghai Xinxing Medicine Recent Developments/Updates

Table 115. SinoCell Tech Company Information

Table 116. SinoCell Tech Description and Business Overview

Table 117. SinoCell Tech Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 118. SinoCell Tech Human Factor VIII Concentrate Product

Table 119. SinoCell Tech Recent Developments/Updates

Table 120. CSL Company Information

Table 121. CSL Description and Business Overview

Table 122. CSL Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 123. CSL Human Factor VIII Concentrate Product

Table 124. CSL Recent Developments/Updates

Table 125. Grifols Company Information

Table 126. Grifols Description and Business Overview

Table 127. Grifols Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 128. Grifols Human Factor VIII Concentrate Product

Table 129. Grifols Recent Developments/Updates

Table 130. Biogen Company Information

Table 131. Biogen Description and Business Overview

Table 132. Biogen Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 133. Biogen Human Factor VIII Concentrate Product

Table 134. Biogen Recent Developments/Updates

Table 135. Octapharma Company Information

Table 136. Octapharma Description and Business Overview

Table 137. Octapharma Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 138. Octapharma Human Factor VIII Concentrate Product

Table 139. Octapharma Recent Developments/Updates

Table 140. NovoNordisk Company Information

Table 141. NovoNordisk Description and Business Overview

Table 142. NovoNordisk Human Factor VIII Concentrate Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 143. NovoNordisk Human Factor VIII Concentrate Product

Table 144. NovoNordisk Recent Developments/Updates

Table 145. Key Raw Materials Lists

Table 146. Raw Materials Key Suppliers Lists

Table 147. Human Factor VIII Concentrate Distributors List

Table 148. Human Factor VIII Concentrate Customers List

Table 149. Human Factor VIII Concentrate Market Trends

Table 150. Human Factor VIII Concentrate Market Drivers

Table 151. Human Factor VIII Concentrate Market Challenges

Table 152. Human Factor VIII Concentrate Market Restraints

Table 153. Research Programs/Design for This Report

Table 154. Key Data Information from Secondary Sources

Table 155. Key Data Information from Primary Sources

Table 156. Authors List of This Report

List of Figures

Figure 1. Product Picture of Human Factor VIII Concentrate

Figure 2. Global Human Factor VIII Concentrate Market Value Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Human Factor VIII Concentrate Market Share by Type: 2024 & 2031

Figure 4. Blood Extraction Product Picture

Figure 5. Recombine Product Picture

Figure 6. Global Human Factor VIII Concentrate Market Value by Application (2020-2031) & (US$ Million)

Figure 7. Global Human Factor VIII Concentrate Market Share by Application: 2024 & 2031

Figure 8. Congenital Coagulation Factor VIII Deficiency

Figure 9. Acquired Factor VIII Deficiency

Figure 10. Von Willebrand's Disease

Figure 11. Global Human Factor VIII Concentrate Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 12. Global Human Factor VIII Concentrate Market Size (2020-2031) & (US$ Million)

Figure 13. Global Human Factor VIII Concentrate Sales (2020-2031) & (K Units)

Figure 14. Global Human Factor VIII Concentrate Average Price (US$/Unit) & (2020-2031)

Figure 15. Human Factor VIII Concentrate Report Years Considered

Figure 16. Human Factor VIII Concentrate Sales Share by Manufacturers in 2024

Figure 17. Global Human Factor VIII Concentrate Revenue Share by Manufacturers in 2024

Figure 18. Global 5 and 10 Largest Human Factor VIII Concentrate Players: Market Share by Revenue in Human Factor VIII Concentrate in 2024

Figure 19. Human Factor VIII Concentrate Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024

Figure 20. Global Human Factor VIII Concentrate Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Figure 21. North America Human Factor VIII Concentrate Sales Market Share by Country (2020-2031)

Figure 22. North America Human Factor VIII Concentrate Revenue Market Share by Country (2020-2031)

Figure 23. United States Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 24. Canada Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 25. Europe Human Factor VIII Concentrate Sales Market Share by Country (2020-2031)

Figure 26. Europe Human Factor VIII Concentrate Revenue Market Share by Country (2020-2031)

Figure 27. Germany Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 28. France Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 29. U.K. Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 30. Italy Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 31. Russia Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 32. Asia Pacific Human Factor VIII Concentrate Sales Market Share by Region (2020-2031)

Figure 33. Asia Pacific Human Factor VIII Concentrate Revenue Market Share by Region (2020-2031)

Figure 34. China Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 35. Japan Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 36. South Korea Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 37. India Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 38. Australia Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 39. China Taiwan Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 40. Southeast Asia Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 41. Latin America Human Factor VIII Concentrate Sales Market Share by Country (2020-2031)

Figure 42. Latin America Human Factor VIII Concentrate Revenue Market Share by Country (2020-2031)

Figure 43. Mexico Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 44. Brazil Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 45. Argentina Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 46. Middle East and Africa Human Factor VIII Concentrate Sales Market Share by Country (2020-2031)

Figure 47. Middle East and Africa Human Factor VIII Concentrate Revenue Market Share by Country (2020-2031)

Figure 48. Turkey Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 49. Saudi Arabia Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 50. UAE Human Factor VIII Concentrate Revenue Growth Rate (2020-2031) & (US$ Million)

Figure 51. Global Sales Market Share of Human Factor VIII Concentrate by Type (2020-2031)

Figure 52. Global Revenue Market Share of Human Factor VIII Concentrate by Type (2020-2031)

Figure 53. Global Human Factor VIII Concentrate Price (US$/Unit) by Type (2020-2031)

Figure 54. Global Sales Market Share of Human Factor VIII Concentrate by Application (2020-2031)

Figure 55. Global Revenue Market Share of Human Factor VIII Concentrate by Application (2020-2031)

Figure 56. Global Human Factor VIII Concentrate Price (US$/Unit) by Application (2020-2031)

Figure 57. Human Factor VIII Concentrate Value Chain

Figure 58. Channels of Distribution (Direct Vs Distribution)

Figure 59. Bottom-up and Top-down Approaches for This Report

Figure 60. Data Triangulation

Figure 61. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Coagulation Factors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Factor XIII Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Coagulation Factor Ⅷ Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Prothrombin Complex Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Coagulation Factor Concentrate Market Research Report 2025

Global Acquired Hemophilia Treatment Market Insights Forecast to 2030

Global Recombinant Coagulation Factor Concentrate Market Research Report 2024

Fc Fusion Protein for Haemophilia Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemodialysis Concentrates Market Research Report 2025

Global Haemophilia Treatment Market Insights Forecast to 2030

Eloctate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Hemostatic Product Market Research Report 2025

Plasma derived Factor VIII Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Human Fibrinogen Concentrate Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Acquired hemophilia A Treatment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Recombinant Coagulation Factor Ⅷ for Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Recombinant Human Coagulation Factor VIII for Injection Market Research Report 2024

Cryopreserved Human Hepatocytes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Mineral Scanner Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-30K19136

Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Medical Antiseptics Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-20E19579

Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Diaminodiphenyl Sulfone Series Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-39I19278

Wed May 28 00:00:00 UTC 2025

Add to Cart

Global Analytical and Technical Consulting Service Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-14Q15724

Wed May 28 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions